Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This triple-hormone mechanism is one of the key differences between retatrutide and other medical weight loss peptides currently available, such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1 and GIP receptor agonist), and is one reason it has attracted so much attention in clinical obesity research
Monitor your response carefully and contact your pharmacy
In general, PT-141 should not be administered more than twice weekly or eight times monthly, since overly frequent administration can increase the risk of side effects such as skin darkening
It is significantly boosting the risk of diabetes development
Our weight loss consultation is free
US$ 25.03
US$ 27.19
US$ 29.56
US$ 25.05
US$ 26.72
US$ 23.73
US$ 22.49
